View in EDS HTML Full Text PDF Full Text

Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database

Saved in:

Bibliographic Details
Title:	Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database
Authors:	Ishibashi, Ryoichi^1,2 (AUTHOR) ishibashi-cib@umin.net, Inaba, Yosuke³ (AUTHOR), Koshizaka, Masaya^2,4 (AUTHOR), Takatsuna, Yoko^5,6 (AUTHOR), Tatsumi, Tomoaki⁶ (AUTHOR), Shiko, Yuki³ (AUTHOR), Kashiwagi, Yusuke⁷ (AUTHOR), Maezawa, Yoshiro² (AUTHOR), Kawasaki, Yohei³ (AUTHOR), Kawakami, Eiryo⁷ (AUTHOR), Yamamoto, Shuichi⁶ (AUTHOR), Yokote, Koutaro² (AUTHOR)
Source:	Diabetes, Obesity & Metabolism. Apr2024, Vol. 26 Issue 4, p1510-1518. 9p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	14628902
DOI:	10.1111/dom.15454